参考文献:1.Rennard S, Decramer M, Calverley PM et al (2002) Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey. Eur Respir J 20:799–805CrossRef PubMed 2.Han MK, Agusti A, Calverley PM et al (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182:598–604CrossRef PubMed 3.From the global strategy for the diagnosis (2014) Management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.org/ 4.Kessler R, Partridge MR, Miravitlles M et al (2011) Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 37:264–272CrossRef PubMed 5.de Oliveira JC, de Carvalho Aguiar I, de Oliveira Beloto AC et al (2013) Clinical significance in COPD patients followed in a real practice. Multidiscip Respir Med 8:43PubMedCentral CrossRef PubMed 6.Miravitlles M, Ferrer J, Baro E et al (2013) Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med 107:1977–1985CrossRef PubMed 7.Burgel PR, Nesme-Meyer P, Chanez P et al (2009) Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 135:975–982CrossRef PubMed 8.Vestbo J, Prescott E, Lange P (1996) Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 153:1530–1535CrossRef PubMed 9.Ekberg-Aronsson M, Pehrsson K, Nilsson JA et al (2005) Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 6:98PubMedCentral CrossRef PubMed 10.Seemungal TA, Donaldson GC, Bhowmik A et al (2000) Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:1608–1613CrossRef PubMed 11.Calverley P, Pauwels DR, Lofdahl CG et al (2005) Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 26:406–413CrossRef PubMed 12.Birring SS, Fleming T, Matos S et al (2008) The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J 31:1013–1018CrossRef PubMed 13.Faruqi S, Thompson R, Wright C et al (2011) Quantifying chronic cough: objective versus subjective measurements. Respirology 16:314–320CrossRef PubMed 14.Smith J, Owen E, Earis J et al (2006) Cough in COPD: correlation of objective monitoring with cough challenge and subjective assessments. Chest 130:379–385CrossRef PubMed 15.Decalmer SC, Webster D, Kelsall AA et al (2007) Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring? Thorax 62:329–334PubMedCentral CrossRef PubMed
作者单位:Michael G. Crooks (1) Yvette Hayman (1) Andrew Innes (1) James Williamson (1) Caroline E. Wright (1) Alyn H. Morice (1)
1. Centre for Cardiovascular and Metabolic Research, Hull York Medical School, Hull, UK
刊物类别:Medicine
刊物主题:Medicine & Public Health Pneumology and Respiratory System
出版者:Springer New York
ISSN:1432-1750
文摘
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Cough and sputum production are associated with adverse outcomes in COPD and are common during COPD exacerbation (AE-COPD). This study of objective cough monitoring using the Hull Automated Cough Counter and Leicester Cough Monitor software confirms that this system has the ability to detect a significant decrease in cough frequency during AE-COPD convalescence. The ability to detect clinically meaningful change indicates a potential role in home monitoring of COPD patients. Keywords COPD Cough Exacerbation Outpatient monitoring Telehealth